Relatively low expression levels of CTLA4, HAVCR2, LAG3, and PDCD1LG2 can be observed in the group of patients with metastasis (p < 0.05) (Figure 6A), which may indicate and predict a poor prognosis in patients with osteosarcoma. This evidence concerns the gene HAVCR2 and osteosarcoma.